Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potential role of thiazolidinediones in older diabetic patients.

× No keyword cloud information.

16 in total

1. A new potentiator of insulin action. Post-receptor activation in vitro.

Authors: M Kobayashi; M Iwasaki; S Ohgaku; H Maegawa; N Watanabe; Y Shigeta
Journal: FEBS Lett Date: 1983-10-31 Impact factor: 4.124

2. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.

Authors: R W Stevenson; N J Hutson; M N Krupp; R A Volkmann; G F Holland; J F Eggler; D A Clark; R K McPherson; K L Hall; B H Danbury
Journal: Diabetes Date: 1990-10 Impact factor: 9.461

3. Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform.

Authors: M K Sinha; C Raineri-Maldonado; C Buchanan; W J Pories; C Carter-Su; P F Pilch; J F Caro
Journal: Diabetes Date: 1991-04 Impact factor: 9.461

4. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.

Authors: T Fujiwara; S Yoshioka; T Yoshioka; I Ushiyama; H Horikoshi
Journal: Diabetes Date: 1988-11 Impact factor: 9.461

5. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.

Authors: H Ikeda; S Taketomi; Y Sugiyama; Y Shimura; T Sohda; K Meguro; T Fujita
Journal: Arzneimittelforschung Date: 1990-02

6. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

Authors: C Hofmann; K Lorenz; J R Colca
Journal: Endocrinology Date: 1991-10 Impact factor: 4.736

7. Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture.

Authors: H Maegawa; R Tachikawa-Ide; S Ugi; M Iwanishi; K Egawa; R Kikkawa; Y Shigeta; A Kashiwagi
Journal: Biochem Biophys Res Commun Date: 1993-12-30 Impact factor: 3.575

8. Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes.

Authors: K Mimura; F Umeda; S Hiramatsu; S Taniguchi; Y Ono; N Nakashima; K Kobayashi; M Masakado; Y Sako; H Nawata
Journal: Diabet Med Date: 1994 Aug-Sep Impact factor: 4.359

9. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.

Authors: T Fujita; Y Sugiyama; S Taketomi; T Sohda; Y Kawamatsu; H Iwatsuka; Z Suzuoki
Journal: Diabetes Date: 1983-09 Impact factor: 9.461

10. Diabetes in the elderly: the Oxford Community Diabetes Study.

Authors: H A Neil; A V Thompson; M Thorogood; G H Fowler; J I Mann
Journal: Diabet Med Date: 1989 Sep-Oct Impact factor: 4.359